About Mike Rice
Mike Rice is a board member and strategic advisor at Mercury Bio, which develops therapies for Parkinson’s and Alzheimer’s disease. He joined the board in November 2023. He previously spent more than 17 years at BioLife Solutions, most recently as chairman and chief executive officer. He led BioLife’s strategy for preservation media used in nearly 1,000 applications, including most approved cell therapies and many cell and gene therapy trials.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Mike Rice in the role, so the role may have started earlier or lasted longer.
Mercury Bio, Inc. Current
strategic advisor (2023 – Present)
Director
2023 – Present · Santa Fe, NM
Mercury Bio develops precision medicines that carry therapeutic cargo into cells affected by Parkinson’s and Alzheimer’s disease.
BI
Biolife Solutions Inc.
Executive officer
Chairman and CEO
2007 – 2023 · Public company (BLFS)
VI
Vincerx Pharma, Inc.
Chief Operating Officer and director
2020 · Public company (VINC)
Key Colleagues at Startups
The people Mike Rice works with at each company, as listed on that company's latest Form D.
Mercury Bio, Inc. · Form D, Nov 13, 2026
SK
Steve Kiziuk
CEO, Mountain Vector Energy and director
AK
Alex Koglin
Director
Dana Barnard
Chairman of the Board
BM
Bruce McCormick
Chief Executive Officer and director
KM
Kevin McDonald
Director
JT
John Tomes
Director of Finance, Mercury Bio
BS
Bryan Scheer
CEO, InREACH HEALTHCARE & ADVA CERA, director